NASDAQ:PAHC - Phibro Animal Health Stock Price, News & Analysis

$31.21
+1.18 (+3.93 %)
(As of 08/18/2019 05:51 AM ET)
Today's Range
$30.09
Now: $31.21
$31.39
50-Day Range
$28.89
MA: $30.70
$32.54
52-Week Range
$27.32
Now: $31.21
$54.62
Volume320,100 shs
Average Volume130,748 shs
Market Capitalization$1.26 billion
P/E Ratio17.94
Dividend Yield1.60%
Beta0.69
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PAHC
CUSIPN/A
Phone201-329-7300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$820 million
Cash Flow$2.5271 per share
Book Value$4.58 per share

Profitability

Net Income$64.88 million

Miscellaneous

Employees1,500
Market Cap$1.26 billion
Next Earnings Date8/27/2019 (Confirmed)
OptionableOptionable

Receive PAHC News and Ratings via Email

Sign-up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter.


Phibro Animal Health (NASDAQ:PAHC) Frequently Asked Questions

What is Phibro Animal Health's stock symbol?

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health declared a quarterly dividend on Monday, July 29th. Shareholders of record on Wednesday, September 4th will be given a dividend of $0.12 per share on Wednesday, September 25th. This represents a $0.48 annualized dividend and a yield of 1.54%. The ex-dividend date is Tuesday, September 3rd. View Phibro Animal Health's Dividend History.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Corp (NASDAQ:PAHC) issued its quarterly earnings data on Monday, May, 6th. The company reported $0.39 EPS for the quarter, missing the Zacks' consensus estimate of $0.43 by $0.04. The business had revenue of $205.70 million for the quarter, compared to analyst estimates of $214.94 million. Phibro Animal Health had a return on equity of 33.77% and a net margin of 8.12%. The company's revenue was down 1.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.46 EPS. View Phibro Animal Health's Earnings History.

When is Phibro Animal Health's next earnings date?

Phibro Animal Health is scheduled to release their next quarterly earnings announcement on Tuesday, August 27th 2019. View Earnings Estimates for Phibro Animal Health.

How can I listen to Phibro Animal Health's earnings call?

Phibro Animal Health will be holding an earnings conference call on Wednesday, August 28th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8778535634.

What price target have analysts set for PAHC?

4 equities research analysts have issued 12-month price objectives for Phibro Animal Health's shares. Their forecasts range from $25.00 to $46.00. On average, they expect Phibro Animal Health's stock price to reach $37.6667 in the next twelve months. This suggests a possible upside of 20.7% from the stock's current price. View Analyst Price Targets for Phibro Animal Health.

What is the consensus analysts' recommendation for Phibro Animal Health?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last year. There are currently 2 sell ratings, 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Phibro Animal Health.

Has Phibro Animal Health been receiving favorable news coverage?

News articles about PAHC stock have been trending negative on Sunday, according to InfoTrie Sentiment. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Phibro Animal Health earned a news sentiment score of -2.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Phibro Animal Health.

Are investors shorting Phibro Animal Health?

Phibro Animal Health saw a increase in short interest in July. As of July 31st, there was short interest totalling 796,900 shares, an increase of 30.3% from the June 30th total of 611,800 shares. Based on an average trading volume of 165,700 shares, the days-to-cover ratio is currently 4.8 days. Approximately 3.9% of the company's shares are short sold. View Phibro Animal Health's Current Options Chain.

Who are some of Phibro Animal Health's key competitors?

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Intercept Pharmaceuticals (ICPT), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Zoetis (ZTS), Booking (BKNG), Ophthotech (OPHT) and RetailMeNot (SALE).

Who are Phibro Animal Health's key executives?

Phibro Animal Health's management team includes the folowing people:
  • Mr. Jack Clifford Bendheim, Chairman, Pres & CEO (Age 72)
  • Mr. Larry L. Miller, Chief Operating Officer (Age 55)
  • Mr. Dean J. Warras, Pres of Animal Health & Nutrition - North America (Age 50)
  • Mr. Richard G. Johnson, Chief Financial Officer (Age 70)
  • Mr. Thomas G. Dagger, Sr. VP, Gen. Counsel & Corp. Sec. (Age 61)

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.04%), Vanguard Group Inc. (5.58%), Fiduciary Management Inc. WI (2.65%), Janus Henderson Group PLC (2.37%), Janus Henderson Group PLC (2.37%) and Renaissance Technologies LLC (1.87%). Company insiders that own Phibro Animal Health stock include Bfi Co, Llc, Daniel M Bendheim, Dean J Warras, Gerald K Carlson, Jack Bendheim, Larry Lee Miller and Richard G Johnson. View Institutional Ownership Trends for Phibro Animal Health.

Which institutional investors are selling Phibro Animal Health stock?

PAHC stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, D. E. Shaw & Co. Inc., Prudential Financial Inc., Wells Fargo & Company MN, Citadel Advisors LLC, AQR Capital Management LLC and Invesco Ltd.. Company insiders that have sold Phibro Animal Health company stock in the last year include Bfi Co, Llc, Daniel M Bendheim, Dean J Warras and Jack Bendheim. View Insider Buying and Selling for Phibro Animal Health.

Which institutional investors are buying Phibro Animal Health stock?

PAHC stock was purchased by a variety of institutional investors in the last quarter, including Fiduciary Management Inc. WI, Janus Henderson Group PLC, Janus Henderson Group PLC, Nuveen Asset Management LLC, Marshall Wace LLP, Vanguard Group Inc., Tocqueville Asset Management L.P. and Bank of America Corp DE. View Insider Buying and Selling for Phibro Animal Health.

How do I buy shares of Phibro Animal Health?

Shares of PAHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Phibro Animal Health's stock price today?

One share of PAHC stock can currently be purchased for approximately $31.21.

How big of a company is Phibro Animal Health?

Phibro Animal Health has a market capitalization of $1.26 billion and generates $820 million in revenue each year. The company earns $64.88 million in net income (profit) each year or $1.74 on an earnings per share basis. Phibro Animal Health employs 1,500 workers across the globe.View Additional Information About Phibro Animal Health.

What is Phibro Animal Health's official website?

The official website for Phibro Animal Health is http://www.pahc.com/.

How can I contact Phibro Animal Health?

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The company can be reached via phone at 201-329-7300 or via email at [email protected]


MarketBeat Community Rating for Phibro Animal Health (NASDAQ PAHC)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  246 (Vote Outperform)
Underperform Votes:  298 (Vote Underperform)
Total Votes:  544
MarketBeat's community ratings are surveys of what our community members think about Phibro Animal Health and other stocks. Vote "Outperform" if you believe PAHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PAHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Featured Article: What is Call Option Volume?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel